Xu Dilin

Lin Jiajia^*,1, 

Mak Shinghung^*,2, 

Zheng Jiacheng¹, 

Wang Jialing¹, 

Xu Dilin¹, 

Hu Shengquan², 

Zhang Zaijun³, 

Wang Qinwen¹, 

Han Yifan^2,4, 

Cui Wei^1,2 

¹Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, 

²Department of Applied Biology and Chemistry Technology, Institute of Modern Chinese Medicine, The Hong Kong Polytechnic University, 

³Institute of New Drug Research, Guangdong Provincial Key Laboratory of Pharmacodynamic, Constituents of Traditional Chinese Medicine & New Drug Research, College of Pharmacy, Jinan University, 

⁴, International Joint Laboratory (SYSU-PolyU HK) of Novel Anti-Dementia Drugs of Guangdong 

Huang Chunhui^1,2, 

Xu Dilin¹, 

Zhang Ke¹, 

Shentu Jieyi², 

Yan Sicheng¹, 

Wu Dapeng³, 

Wang Qinwen¹, 

Cui Wei^1,2 

¹Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, 

²Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Ningbo University, 

³School of Materials Science and Chemical Engineering, Ningbo University